Free Trial

Keurig Dr Pepper (KDP) Stock Forecast & Price Target

Keurig Dr Pepper logo
$33.11 +0.30 (+0.91%)
Closing price 03/13/2025 04:00 PM Eastern
Extended Trading
$33.27 +0.16 (+0.48%)
As of 07:38 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Keurig Dr Pepper - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
6
Buy
8

Based on 14 Wall Street analysts who have issued ratings for Keurig Dr Pepper in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 14 analysts, 6 have given a hold rating, and 8 have given a buy rating for KDP.

Consensus Price Target

$38.23
15.47% Upside
According to the 14 analysts' twelve-month price targets for Keurig Dr Pepper, the average price target is $38.23. The highest price target for KDP is $42.00, while the lowest price target for KDP is $34.00. The average price target represents a forecasted upside of 15.47% from the current price of $33.11.
Get the Latest News and Ratings for KDP and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Keurig Dr Pepper and its competitors.

Sign Up

KDP Analyst Ratings Over Time

TypeCurrent Forecast
3/14/24 to 3/14/25
1 Month Ago
2/13/24 to 2/12/25
3 Months Ago
12/15/23 to 12/14/24
1 Year Ago
3/15/23 to 3/14/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
8 Buy rating(s)
9 Buy rating(s)
9 Buy rating(s)
7 Buy rating(s)
Hold
6 Hold rating(s)
6 Hold rating(s)
6 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$38.23$37.50$38.50$36.64
Forecasted Upside15.47% Upside18.41% Upside14.75% Upside26.33% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Remove Ads

KDP Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

KDP Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Keurig Dr Pepper Stock vs. The Competition

TypeKeurig Dr PepperConsumer Staples CompaniesS&P 500
Consensus Rating Score
2.57
2.47
2.54
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside15.47% Upside53.39% Upside22.09% Upside
News Sentiment Rating
Positive News

See Recent KDP News
Positive News
Positive News
Remove Ads
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
2/27/2025Barclays
3 of 5 stars
 Set Target$39.00+15.59%
2/26/2025JPMorgan Chase & Co.
2 of 5 stars
Andrea Teixeira
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$37.00 ➝ $40.00+17.32%
2/26/2025Morgan Stanley
3 of 5 stars
Dara Mohsenian
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetEqual Weight ➝ Equal Weight$36.00 ➝ $38.00+11.01%
2/25/2025Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Overweight
2/25/2025Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Mike Lavery
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$35.00+2.58%
2/25/2025UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy
1/8/2025TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold ➝ Hold$39.00 ➝ $36.00+16.96%
12/12/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$37.00 ➝ $39.00+17.26%
10/25/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
F. Falorni
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$43.00 ➝ $40.00+15.44%
10/25/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$42.00 ➝ $41.00+17.41%
10/25/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$41.00 ➝ $42.00+20.27%
9/5/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Ottenstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
6/24/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
K. Grundy
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$36.00+4.71%
6/17/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeSell ➝ Hold$27.00 ➝ $34.00-0.12%
2/26/2024Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$37.00 ➝ $35.00+17.53%
12/22/2023HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageHold$37.00+13.78%
10/12/2023Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$40.00 ➝ $37.00+26.32%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 07:58 AM ET.


Should I Buy Keurig Dr Pepper Stock? KDP Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, March 7, 2025. Please send any questions or comments about these Keurig Dr Pepper pros and cons to contact@marketbeat.com.

Keurig Dr Pepper
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Keurig Dr Pepper Inc.:

  • The stock is currently trading at $34.13, which is below the average target price of $38.23 set by analysts, indicating potential for price appreciation.
  • Keurig Dr Pepper Inc. reported a quarterly earnings per share (EPS) of $0.58, exceeding analysts' expectations of $0.57, showcasing strong financial performance.
  • The company has a solid revenue growth of 5.2% year-over-year, with quarterly revenue reaching $4.07 billion, indicating a healthy demand for its products.
  • With a net margin of 15.04%, Keurig Dr Pepper Inc. demonstrates effective cost management and profitability, which can be attractive to investors.
  • The company has received multiple buy ratings from analysts, reflecting positive sentiment and confidence in its future performance.

Keurig Dr Pepper
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Keurig Dr Pepper Inc. for these reasons:

  • The company has a relatively high dividend payout ratio of 87.62%, which may limit its ability to reinvest profits back into the business for growth.
  • TD Cowen recently lowered its price target for the stock from $39.00 to $36.00, indicating some analysts' concerns about future performance.
  • The stock has a beta of 0.61, suggesting lower volatility compared to the market, which may not appeal to investors seeking high-risk, high-reward opportunities.
  • Despite positive earnings, the current debt-to-equity ratio of 0.50 indicates that the company is using a moderate amount of debt to finance its operations, which could pose risks in a rising interest rate environment.
  • With six analysts rating the stock as a hold, there may be a lack of strong bullish sentiment, which could limit upward price movement in the near term.

KDP Forecast - Frequently Asked Questions

According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for Keurig Dr Pepper is $38.23, with a high forecast of $42.00 and a low forecast of $34.00.

14 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Keurig Dr Pepper in the last twelve months. There are currently 6 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" KDP shares.

According to analysts, Keurig Dr Pepper's stock has a predicted upside of 15.47% based on their 12-month stock forecasts.

Keurig Dr Pepper has been rated by research analysts at Barclays, JPMorgan Chase & Co., Morgan Stanley, Piper Sandler, TD Cowen, UBS Group, and Wells Fargo & Company in the past 90 days.

Analysts like Keurig Dr Pepper more than other "consumer staples" companies. The consensus rating for Keurig Dr Pepper is Moderate Buy while the average consensus rating for "consumer staples" companies is Hold. Learn more on how KDP compares to other companies.


This page (NASDAQ:KDP) was last updated on 3/14/2025 by MarketBeat.com Staff
From Our Partners